Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS [Phase 1]
Phase 1 trial SENTI-202 evaluating off-the-shelf logic-gated CAR NK cells for CD33 and/or FLT3-expressing hematologic cancers including acut…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: National Longitudinal Cohort of Hematological Diseases
Recruiting for a national longitudinal cohort study of hematological diseases sponsored by the Institute of Hematology & Blood Diseases Hosp…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Quality of Life-Guided Transfusion in Refractory MDS or AML [NA]
A clinical trial evaluating quality-of-life-guided transfusion in adults with refractory myelodysplastic syndromes or acute myeloid leukemia…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML [Phase 1, Phase 2]
This clinical trial update indicates a Phase 1/2 study evaluating venetoclax in combination with ivosidenib and azacitidine for newly diagno…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation [NA]
The document updates a clinical trial evaluating an electronic health mindfulness-based music therapy intervention for patients undergoing a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) [Phase 1]
A Phase 1 clinical trial evaluating STX-0712 in patients with advanced hematologic malignancies is currently recruiting. The study includes …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT [Phase 1]
This is an active Phase 1 clinical trial evaluating Gamma Delta T-cell Infusion for Acute Myeloid Leukemia at high risk of relapse after all…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial evaluating alternating regimens of cladribine plus low-dose cytarabine with decitabine for acute myeloid leukemia or high-risk…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax [Phase 1, Phase 2]
A multi-site Phase 1/2 trial evaluating a three-drug regimen (tagraxofusp, azacitidine, and venetoclax) for measurable residual disease in a…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis [Phase 2]
Phase 2 clinical trial evaluating reduced-dose post-transplant cyclophosphamide as GVHD prophylaxis in HLA-mismatched unrelated donor periph…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission [Phase 2]
This clinical trial update outlines a Phase 2 study evaluating a DC/AML fusion cell vaccine versus observation in AML patients who achieved …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML [Phase 2]
A Phase 2 clinical trial is evaluating alternating VA and low-dose CHA regimens for unfit, newly diagnosed acute myeloid leukemia.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS [Phase 1]
Phase 1 study evaluating APL-4098 alone and in combination for adults with acute myeloid leukemia or myelodysplastic syndromes; currently re…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients [NA]
This clinical trial update reports ongoing recruitment for a study investigating epigenetic markers in elderly patients with acute myeloid l…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Effect of Hypnosis and Virtual Reality on Anxiety During Treatment for Acute Myeloid Leukemia [NA]
This clinical trial aims to assess whether hypnosis combined with virtual reality can reduce anxiety in patients undergoing treatment for ac…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia [Phase 1]
A Phase 1 trial evaluating dalbavancin-based prophylaxis in children and adolescents with high-risk leukemia; the study is currently recruit…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
A clinical trial evaluating toxicity determinants and responses to azacitidine and venetoclax in acute myeloid leukemia. It is currently rec…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT [Phase 1]
A Phase I clinical trial for patients with advanced hematologic malignancies undergoing allogeneic hematopoietic cell transplantation is cur…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer [Phase 2]
Phase 2 clinical trial evaluating FLAG-Ida chemotherapy followed by reduced-intensity total body irradiation and donor hematopoietic cell tr…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT [Phase 2]
Phase 2 clinical trial comparing two reduced-intensity conditioning regimens—clofarabine vs. fludarabine—in adults with acute myeloid leukem…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Expanded Access to Venetoclax
Expanded access to venetoclax is being offered for multiple hematologic cancers, including chronic lymphocytic leukemia, multiple myeloma, A…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms [Phase 1]
Phase 1 clinical trial evaluating a triple combination of navitoclax, venetoclax, and decitabine for advanced myeloid neoplasms. The study i…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy [Phase 3]
Phase 3 clinical trial evaluating a digital health intervention for self-management and telemonitoring in CAR-T therapy is currently recruit…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Romiplostim N01 for Platelet Recovery After Haploidentical HSCT [Phase 1]
Phase 1 clinical trial evaluating Romiplostim N01 for platelet recovery after haploidentical hematopoietic stem cell transplantation. The st…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia [Phase 2]
Phase 2 clinical trial evaluating Total Marrow and Lymphoid Irradiation as a conditioning regimen before hematopoietic cell transplantation …